| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 08/19/2008 | US7414031 5-nitro-nucleoside compounds for treating viral infections |
| 08/19/2008 | CA2151801C 3'-modified oligonucleotide derivatives |
| 08/14/2008 | WO2008098036A1 Product preparation and recovery from thermolysis of lignocellulosics in ionic liquids |
| 08/14/2008 | WO2008095993A1 Novel nucleoside analogs for treatment of viral infections |
| 08/14/2008 | WO2007106561A3 Prevention and treatment of cancer and other diseases |
| 08/14/2008 | US20080194502 2' protected nucleoside monomers protected with orthoester-type and acyl carbonate groups; solid phase synthesis of RNA, oxidation and deprotecting, removal from the support |
| 08/14/2008 | US20080194498 Avermectins and Avermectin Monosacharides Substituted in the 4'-and 4" Position Having Pesticidal Properties |
| 08/14/2008 | US20080193452 Sulfated nucleoside derivatives including ribonucleoside mono- and disulfates derived from guanine, adenosine, and cytidine |
| 08/14/2008 | CA2675462A1 Novel nucleoside analogs for treatment of viral infections |
| 08/13/2008 | EP1956028A2 Photolabile compound, oligomer probe array and substrate for oligomer probe array containing the same, and manufacturing method of the same |
| 08/13/2008 | EP1324761B1 Uridine therapy for patients with elevated purine levels |
| 08/13/2008 | EP1322784B1 Method for screening of genomic DNA, in particular in relation to transgenic and targeted mutagenesis |
| 08/13/2008 | CN101243102A Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 08/13/2008 | CN101243101A Homogemcitabines |
| 08/13/2008 | CN101240003A Method for preparing clofarabine raw material medicament |
| 08/13/2008 | CN101240002A Fatty acylaminoacylcytarabine conjugate, preparation method and application thereof |
| 08/13/2008 | CN101240001A 2'-fluoro nucleotide |
| 08/13/2008 | CN100410255C Inosine derivatives and production methods therefor |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/07/2008 | WO2008093764A1 Composition for prevention or treatment of diabetes |
| 08/07/2008 | WO2008093763A1 Agent for activating or improving neuronal cell or brain function |
| 08/07/2008 | US20080188668 Process for preparing substituted benzimidazole compounds |
| 08/07/2008 | US20080188440 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080187979 Using forceful pipetting to agitate nucleic acid extraction fluid |
| 08/06/2008 | EP1397377B1 Calix (4) arene-nucleoside and calix (4) arene-oligonucleotide hybrids |
| 08/06/2008 | CN101238141A New labelling strategies for the sensitive detection of analytes |
| 08/06/2008 | CN101235064A Thionucleotide monomer capable of deprotecting |
| 08/06/2008 | CN100408591C Crystal of pyrimidine nucleoside derivative |
| 08/06/2008 | CN100408590C Method for modifying nucleoside by spiro pyran and spiro oxazine photo chromic compound |
| 08/05/2008 | US7408051 Containing at least one 2'-substituted-2'-Deoxy-pseudoisocytidine unit no more than 4 nucleotides from the 3' terminus of the primer that provide reduced formation of primer-dimers during amplification reactions |
| 07/31/2008 | WO2008090829A1 Process for production of ribonucleic acid compound |
| 07/31/2008 | WO2008090749A1 Agent for modification of sh group |
| 07/31/2008 | WO2008090151A1 Antiviral compounds |
| 07/31/2008 | WO2008090046A1 Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone |
| 07/31/2008 | WO2007135380A3 Antiparasitic compounds and compositions |
| 07/31/2008 | US20080182816 Utilizing prodrug technique to couple polysaccharides containing galactose with a parent compound through different bridge linkage to derive conjugates; polysaccharide component protects 5-fluorouracil(5-FU) from absorption in the upper gastrointestinal tract, delivers the 5-FU to colorectal area |
| 07/31/2008 | US20080182815 Act against several infective agents, and most notably Bacillus spp. and Staphylococcus spp., including infection caused by methicillin-resistant Staphylococcus aureus (MRSA) |
| 07/31/2008 | CA2675934A1 Antiviral compounds |
| 07/30/2008 | EP1950220A1 Stable salt of 3'-phosphoadenosine 5'-phosphosulfate |
| 07/30/2008 | EP1891087A4 Process of making an alpha-anomer enriched 2-deoxy-2,2-diflouro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside |
| 07/30/2008 | EP1392868B1 Method for the synthesis of dna sequences using photo-labile linkers |
| 07/30/2008 | CN101233144A 稳定的nad/nadh衍生物 Stable nad / nadh derivatives |
| 07/30/2008 | CN101233141A Ascomycin crystalline forms and preparation thereof |
| 07/30/2008 | CN100406005C Compound and method for therapeutic intervention in preventing diabetic complications |
| 07/29/2008 | US7405297 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
| 07/29/2008 | US7405282 UTR tag assay for gene function discovery |
| 07/29/2008 | US7405204 Nucleoside compounds for treating viral infections |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2307002C Antitumour uridine analogues |
| 07/29/2008 | CA2295628C Stable formulations comprising a nucleotide and a freeze drying additive |
| 07/24/2008 | WO2008089105A2 Antiviral nucleoside analogs |
| 07/24/2008 | WO2008088779A2 Solid state forms of 5-azacytidine and processes for preparation thereof |
| 07/24/2008 | WO2008087862A1 Agent against periodontal disease |
| 07/24/2008 | WO2008087839A1 Process for production of crystal of purine nucleoside compound |
| 07/24/2008 | US20080177055 Methods for preparing 2-alkynyladenosine deriviatives |
| 07/24/2008 | US20080176816 Method of making and using an adenosine analogue |
| 07/24/2008 | CA2712073A1 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 07/24/2008 | CA2674589A1 Antiviral nucleoside analogs |
| 07/23/2008 | EP1947104A2 Method and compositions for identifying and characterizing hepatitis C |
| 07/23/2008 | EP1947092A1 Nucleic acid base having perfluoroalkyl group and method for producing the same |
| 07/23/2008 | EP1706414B1 Process for fluorocytidine derivatives |
| 07/23/2008 | CN101225096A Method for preparing deoxyribonucleotide |
| 07/22/2008 | US7402677 used to label biological molecules such as proteins, polypeptides, amino acids, nucleic acids, and nucleotides, in clothing dyes, and in cosmetics; use in multiplex detection |
| 07/22/2008 | US7402671 UV excitable fluorescent energy transfer dyes |
| 07/22/2008 | US7402588 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/17/2008 | WO2008083465A1 Pyrimidine derivatives as anticancer agents |
| 07/17/2008 | US20080171863 Reacting fluorine salt containing radioactive fluorine-18 with alkyl halide or alkyl sulfonate in presence of alcohol; decreased reaction time; high yield; reduces the formation of side products |
| 07/17/2008 | US20080171859 diagnostic or therapeutic agents; base and acid stable; telomerase enzyme inhibitors |
| 07/17/2008 | US20080168707 Additive for hydrocarbon fuel and related processes consisting of compounds of adenosine phosphates |
| 07/17/2008 | CA2673649A1 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 07/16/2008 | EP1944310A2 Modified oligonucleotides for mismatch discrimination |
| 07/16/2008 | EP1943261A2 Drug-eluting stents coated with non-nucleotide p2y12 receptor antagonist compound |
| 07/16/2008 | EP1943251A2 A1 adenosine receptor agonists |
| 07/16/2008 | EP1942910A2 Drug-eluting stents coated with p2y12 receptor antagonist compound |
| 07/16/2008 | CN101220071A Stable 6-methoxy-2í»,3í»-dideoxy guanine nucleoside, method for preparing the same and medicament composition containing the same |
| 07/16/2008 | CN101220070A Inosine derivative and process for producing the same |
| 07/16/2008 | CN101220069A Method for synthesizing deoxyadenosine compounds |
| 07/16/2008 | CN101220068A A set of geldanamycin derivant and method for preparing the same |
| 07/16/2008 | CN101220031A Acyclic purine nucleosides derivant and method of preparing the same |
| 07/16/2008 | CN101219998A Acyclic pyrimidine nucleoside derivant and method for producing the same |
| 07/16/2008 | CN100402545C Methods and compositions for treating hepatitis c virus |
| 07/16/2008 | CN100402539C Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 07/15/2008 | US7399854 Regents labeled with energy transfer dyes |
| 07/15/2008 | US7399846 Libraries of oligomers labeled with different tags |
| 07/15/2008 | US7399845 For modulating gene expression pathways, including those relying on mechanisms of action such as RNaseH, RNAi and dsRNA enzymes, as well as other antisense mechanisms based on target degradation or target occupancy; of therapeutic, diagnostics, and research applications; nuclease resistance |
| 07/15/2008 | US7399844 Composition for use in the detection of preferential nucleotide sequences in sample |
| 07/15/2008 | US7399754 N2-quinoline or isoquinoline substituted purine derivatives |
| 07/15/2008 | US7399752 Detection, calibration binding of ligand to nucleic acids |
| 07/15/2008 | US7399614 Adding a 5-methylcytosine discriminator to a detection mixture composed of a DNA polymerase and the target nucleic acid hybridized to a primer oligonucleotide having a 3' end nucleotide base paired with its complement and detecting presence of inhibition of hydrogen bond formation |
| 07/10/2008 | WO2008062206A3 Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis c virus |
| 07/10/2008 | US20080167459 Solid phase synthesis |
| 07/10/2008 | CA2673722A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 07/09/2008 | EP1942196A2 Late-pcr |
| 07/09/2008 | EP1940859A1 An improved process for preparation of gemcitabine hydrochloride |
| 07/09/2008 | CN100400107C Drugs for diagnosis of tissue-reproductive activity or treatment of proliferative disease |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396825 Agonists of A2A adenosine receptors for treatment of diabetic nephropathy |
| 07/08/2008 | US7396658 Bioassay for identifying hypothalamic inhibitory factors(HIF) for use in treatment and prevention of liver, cardiovascular and hypotensive disorders |
| 07/08/2008 | CA2298681C Methods and compositions for overcoming resistance to biologic and chemotherapy |